Share-Based Compensation (Tables)

3 Months Ended

Mar. 31, 2021

Share Based Compensation Arrangement By Share Based Payment Award [Line Items]

Summary of Stock Compensation Expense

The following table summarizes stock option compensation expense for the three months ended March 31, 2021 and 2020:

	Three Months Ended March 31,
	2021		2020
Total share-based compensation (benefit) - stock options	$	—	$	7
Income tax benefit (expense)		—		2
Unrecognized compensation expense - stock options		—		—
Weighted-average amortization period remaining	0.0 years		0.0 years

Restricted Shares

Share Based Compensation Arrangement By Share Based Payment Award [Line Items]

Summary of Stock Compensation Expense

The following table summarizes restricted stock compensation expense for the three months ended March 31, 2021 and 2020:

	Three Months Ended March 31,
	2021		2020
Total share-based compensation - restricted stock	$	783	$	600
Income tax benefit		218		167
Unrecognized compensation expense		9,720		7,064
Weighted-average amortization period remaining	2.7 years		2.9 years

Omnibus Plan

Share Based Compensation Arrangement By Share Based Payment Award [Line Items]

Summary of Changes in Restricted Shares

The following table discloses the changes in restricted shares for the three months ended March 31, 2021:

	Omnibus Plan
	Number of Shares			Weighted Average Grant Date Fair Value
Beginning balance, January 1, 2021		383,539		$	18.75
Granted		293,587			19.17
Vested		(37,989	)		17.52
Forfeited		(5,707	)		22.36
Ending balance outstanding at March 31, 2021		633,430		$	18.99

BYB Plan

Share Based Compensation Arrangement By Share Based Payment Award [Line Items]

Summary of Activity in shares Subjected to Options and Weighted Average Exercise Prices

The following table discloses the activity in shares subject to options and the weighted average exercise prices, in actual dollars, for the three months ended March 31, 2021:

	BYB Plan
	Number of Shares			Weighted Average Exercise Price		Intrinsic Value		Weighted Average Remaining Contractual Term (in Years)
Beginning balance, January 1, 2021		1,390,579		$	11.36	$	5,724		4.4
Exercised		(20,000	)		16.25	$	25
Expired		—
Ending balance outstanding at March 31, 2021		1,370,579		$	11.29	$	13,513		4.2
Exercisable at March 31, 2021		1,370,579		$	11.29	$	13,513		4.2

FEB Plan

Share Based Compensation Arrangement By Share Based Payment Award [Line Items]

Summary of Activity in shares Subjected to Options and Weighted Average Exercise Prices

The following table discloses the activity in shares subject to options under the FEB Plan and the weighted average exercise prices, in actual dollars, for the three months ended March 31, 2021:

	FEB Plan
	Number of Shares			Weighted Average Exercise Price		Intrinsic Value		Weighted Average Remaining Contractual Term (in Years)
Beginning balance, January 1, 2021		233,630		$	11.52	$	918		3.3
Exercised		(35,908	)	$	11.84	$	161
Expired		—
Ending balance outstanding at March 31, 2021		197,722		$	11.46	$	1,915		3.6
Exercisable at March 31, 2021		197,722		$	11.46	$	1,915		3.6